0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover0.00%IV87.01%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier31DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Aligos Therapeutics Stock Discussion
📊⚡️📊
Aligos Therapeutics Announces U.S. FDA Clearance of Ind Application for Alg-000184
Aligos Therapeutics Announces U.S. FDA Clearance of IND Application for ALG-000184
No comment yet